Cancer immunotherapy: Breaking the barriers to harvest the crop

Drew Pardoll, James Allison

Research output: Contribution to journalReview articlepeer-review

113 Scopus citations


Successful translation of modern molecular immunology into effective cancer immunotherapy is threatened by regulatory barriers and challenges to the development of novel agents and combinatorial strategies through effective public-private partnerships. For its promise to be fully realized, both the National Cancer Institute and Food and Drug Administration must take active steps to help academic investigators and companies jointly navigate the pathways from laboratory to clinic.

Original languageEnglish (US)
Pages (from-to)887-892
Number of pages6
JournalNature medicine
Issue number9
StatePublished - Sep 2004

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Cancer immunotherapy: Breaking the barriers to harvest the crop'. Together they form a unique fingerprint.

Cite this